What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Yoshihiko Maehara mostly deals with Internal medicine, Surgery, Cancer, Pathology and Cancer research.
His Internal medicine study combines topics in areas such as Gastroenterology and Oncology.
The Liver transplantation, Transplantation, Living donor liver transplantation and Hepatectomy research he does as part of his general Surgery study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science.
His Cancer research is multidisciplinary, relying on both Stomach and Cisplatin.
His work investigates the relationship between Pathology and topics such as Angiogenesis that intersect with problems in Vascular endothelial growth factor.
His work focuses on many connections between Cancer research and other disciplines, such as Carcinogenesis, that overlap with his field of interest in Epigenetics.
His most cited work include:
- A gp130-Src-YAP Module Links Inflammation to Epithelial Regeneration (329 citations)
- Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma (271 citations)
- Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment (240 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Surgery, Gastroenterology, Cancer and Pathology.
In his study, Breast cancer is inextricably linked to Oncology, which falls within the broad field of Internal medicine.
His work on Liver transplantation, Living donor liver transplantation and Retrospective cohort study as part of his general Surgery study is frequently connected to In patient, thereby bridging the divide between different branches of science.
His Gastroenterology study often links to related topics such as Survival rate.
His Cancer research is multidisciplinary, incorporating perspectives in Stomach and Cancer research.
His Pathology research integrates issues from Metastasis and Adenocarcinoma.
He most often published in these fields:
- Internal medicine (40.82%)
- Surgery (29.69%)
- Gastroenterology (20.25%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (40.82%)
- Gastroenterology (20.25%)
- Oncology (16.35%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Oncology, Surgery and Cancer research.
Lung cancer, Colorectal cancer, Chemotherapy, Cancer and Hepatocellular carcinoma are the core of his Internal medicine study.
His research integrates issues of Liver transplantation, Survival rate, Regimen, Clinical endpoint and Hazard ratio in his study of Gastroenterology.
His specific area of interest is Oncology, where Yoshihiko Maehara studies Surgical oncology.
His work on Retrospective cohort study is typically connected to In patient as part of general Surgery study, connecting several disciplines of science.
The Cancer research study combines topics in areas such as Immunohistochemistry, Cancer cell and Carcinogenesis.
Between 2016 and 2021, his most popular works were:
- Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer (78 citations)
- Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma. (52 citations)
- Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma (47 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Yoshihiko Maehara mostly deals with Internal medicine, Lung cancer, Immunohistochemistry, Oncology and Gastroenterology.
Retrospective cohort study, Sarcopenia, Cancer, Multivariate analysis and Survival rate are the subjects of his Internal medicine studies.
His Retrospective cohort study research is included under the broader classification of Surgery.
His Immunohistochemistry study contributes to a more complete understanding of Pathology.
His work on Non small cell as part of general Oncology study is frequently linked to In patient, therefore connecting diverse disciplines of science.
Yoshihiko Maehara interconnects Pathological, Hepatocellular carcinoma, Hazard ratio, Hepatectomy and Prognostic factor in the investigation of issues within Gastroenterology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
